Genesys [GENESYS] vs Nucleus Software [NUCLEUS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Genesys International Corporation Ltd. wins in 4 metrics, Nucleus Software Exports Ltd. wins in 14 metrics, with 0 ties. Nucleus Software Exports Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Genesys International Corporation Ltd. | Nucleus Software Exports Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 27.56 | 14.31 | Nucleus Software Exports Ltd. |
| Price-to-Book Ratio | 1.61 | 2.47 | Genesys International Corporation Ltd. |
| Debt-to-Equity Ratio | 21.42 | 0.93 | Nucleus Software Exports Ltd. |
| PEG Ratio | -0.29 | -0.35 | Genesys International Corporation Ltd. |
| EV/EBITDA | 10.89 | 10.67 | Nucleus Software Exports Ltd. |
| Profit Margin (TTM) | 12.32% | 16.70% | Nucleus Software Exports Ltd. |
| Operating Margin (TTM) | -1.40% | 13.13% | Nucleus Software Exports Ltd. |
| EBITDA Margin (TTM) | N/A | 13.13% | N/A |
| Return on Equity | 10.09% | 20.02% | Nucleus Software Exports Ltd. |
| Return on Assets (TTM) | 7.23% | 14.14% | Nucleus Software Exports Ltd. |
| Free Cash Flow (TTM) | $-1.07B | $1.36B | Nucleus Software Exports Ltd. |
| Dividend Yield | N/A | 1.08% | N/A |
| 1-Year Return | -53.00% | -36.52% | Nucleus Software Exports Ltd. |
| Price-to-Sales Ratio (TTM) | 3.49 | 2.38 | Nucleus Software Exports Ltd. |
| Enterprise Value | $12.05B | $17.27B | Nucleus Software Exports Ltd. |
| EV/Revenue Ratio | 3.79 | 1.96 | Nucleus Software Exports Ltd. |
| Gross Profit Margin (TTM) | 35.62% | 34.16% | Genesys International Corporation Ltd. |
| Revenue per Share (TTM) | $77 | $334 | Nucleus Software Exports Ltd. |
| Earnings per Share (Diluted) | $9.64 | $55.74 | Nucleus Software Exports Ltd. |
| Beta (Stock Volatility) | -0.59 | -0.17 | Genesys International Corporation Ltd. |
Genesys International Corporation Ltd. vs Nucleus Software Exports Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Genesys International Corporation Ltd. | -0.76% | 18.58% | 51.01% | 14.59% | -25.06% | -25.68% |
| Nucleus Software Exports Ltd. | -1.51% | 6.34% | -5.29% | -1.84% | -20.21% | -19.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Genesys International Corporation Ltd. | -53.00% | -1.49% | 177.47% | 383.19% | 42.50% | 4,362.08% |
| Nucleus Software Exports Ltd. | -36.52% | -32.94% | 29.06% | 265.00% | 788.00% | 437.25% |
Performance & Financial Health Analysis: Genesys International Corporation Ltd. vs Nucleus Software Exports Ltd.
| Metric | GENESYS | NUCLEUS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹11.73B | ₹20.83B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 387,369 | 41,580 |
| 90 Day Avg. Volume | 626,055 | 68,471 |
| Last Close | ₹315.30 | ₹739.50 |
| 52 Week Range | ₹198.05 - ₹702.05 | ₹690.00 - ₹1,242.40 |
| % from 52W High | -55.09% | -40.48% |
| All-Time High | ₹1,055.00 (Jan 20, 2025) | ₹1,787.50 (Jan 22, 2024) |
| % from All-Time High | -70.11% | -58.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.15% | 0.07% |
| Quarterly Earnings Growth | -0.95% | -0.41% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.17% |
| Operating Margin (TTM) | -0.01% | 0.13% |
| Return on Equity (TTM) | 0.10% | 0.20% |
| Debt to Equity (MRQ) | 21.42 | 0.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹164.56 | ₹322.51 |
| Cash per Share (MRQ) | ₹24.03 | ₹141.09 |
| Operating Cash Flow (TTM) | ₹-1,066,629,000 | ₹2.28B |
| Levered Free Cash Flow (TTM) | ₹562.23M | ₹1.63B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.08% |
| Last 12-Month Dividend | ₹0.00 | ₹12.50 |
Valuation & Enterprise Metrics Analysis: Genesys International Corporation Ltd. vs Nucleus Software Exports Ltd.
| Metric | GENESYS (Apr 24, 2026) | NUCLEUS (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 27.56 | 14.31 |
| Forward P/E | 19.54 | 12.54 |
| PEG Ratio | -0.29 | -0.35 |
| Price to Sales (TTM) | 3.49 | 2.38 |
| Price to Book (MRQ) | 1.61 | 2.47 |
| Market Capitalization | ||
| Market Capitalization | ₹11.73B | ₹20.83B |
| Enterprise Value | ₹12.05B | ₹17.27B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.79 | 1.96 |
| Enterprise to EBITDA | 10.89 | 10.67 |
| Risk & Other Metrics | ||
| Beta | -0.59 | -0.17 |
| Book Value per Share (MRQ) | ₹164.56 | ₹322.51 |
Financial Statements Comparison: Genesys International Corporation Ltd. vs Nucleus Software Exports Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | GENESYS (2025) | NUCLEUS (2025) |
|---|---|---|
| Revenue/Sales | 3.11B | 8.32B |
| Cost of Goods Sold | 1.34B | 5.50B |
| COGS % of Revenue | 43.1% | 66.1% |
| Gross Profit | 1.77B | 2.82B |
| Gross Margin | 56.9% | 33.9% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 910.69M | 1.54B |
| Operating Margin | 29.3% | 18.4% |
| EBITDA | 1.49B | 1.95B |
| EBITDA Margin | 48.0% | 23.4% |
| Pre-Tax Income | 826.76M | 2.19B |
| Pre-Tax Income % of Revenue | 26.6% | 26.3% |
| Income Tax | 265.73M | 560.50M |
| Income Tax % of Revenue | 8.5% | 6.7% |
| Net Income (Profit) | 561.04M | 1.63B |
| Profit Margin | 18.0% | 19.6% |
Balance Sheet & Liquidity Metrics
| Metric | GENESYS (2025) | NUCLEUS (2025) |
|---|---|---|
| Cash & Equivalents | 33.44M | 501.60M |
| Total Current Assets | 4.55B | 5.44B |
| Total Current Assets % of Revenue | 146.3% | 65.4% |
| Total Current Liabilities | 1.89B | 2.83B |
| Total Current Liabilities % of Revenue | 60.8% | 34.0% |
| Long-Term Debt | 222.61M | 8.80M |
| Long-Term Debt % of Revenue | 7.2% | 0.1% |
| Total Shareholders Equity | 5.57B | 8.14B |
| Retained Earnings | 1.30B | 7.67B |
| Retained Earnings % of Revenue | 41.9% | 92.1% |
| Property, Plant & Equipment | 825.12M | 470.30M |
Cash Flow Statement Comparison
| Metric | GENESYS (2025) | NUCLEUS (2025) |
|---|---|---|
| Operating Cash Flow | -1.07B | 2.28B |
| Operating Cash Flow % of Revenue | -34.3% | 27.3% |
| Capital Expenditures | -433.71M | -152.20M |
| Free Cash Flow | -1.07B | 1.36B |
| FCF Margin | -34.4% | 16.3% |
| Debt Repayment | -97.00M | N/A |
| Common Stock Repurchase | N/A | -892.10M |
Short Interest & Institutional Ownership Analysis
| Metric | GENESYS | NUCLEUS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 41.79M | 26.33M |
| Float Shares | 23.41M | 6.90M |
| % Held by Insiders | 45.13% | 75.61% |
| % Held by Institutions | 2.49% | 2.48% |
| % Held by Public | 52.38% | 21.91% |
Dividend Analysis & Yield Comparison: Genesys International Corporation Ltd. vs Nucleus Software Exports Ltd.
| Metric | GENESYS | NUCLEUS |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹12.50 |
| Last 12-Month Dividend Yield | N/A | 1.08% |
| 3-Year Avg Annual Dividend | ₹0.00 | ₹11.67 |
| 3-Year Avg Dividend Yield | N/A | 0.93% |
| 3-Year Total Dividends | ₹0.00 | ₹35.00 |
| Ex-Dividend Date | N/A | Jul 11, 2025 |